Article · Journal · 2025

Characterizing blood‐based biomarkers of AD pathology using both SIMOA and NULISA technologies among Indigenous Africans: Pioneering experience with the VALIANT Cohort

Alzheimer s & Dementia

Citations: 0from other works
Field-weighted impact: 0.001.00 is the world average for its field and year
Among its field: 52nd percentileby citations, against works of its field and year
Authors: 1from 1 institution

Authors

1 author

Tolulope AkinyemiFirst authorCorresponding
- Lead City University (NG)
as printed: Tolulope O Akinyemi